Skip to content
ADAM VTE & Ibrutinib CV Toxicity episode artwork

Oct 24, 2019 18 min

ADAM VTE & Ibrutinib CV Toxicity

from OncoPharm Hosted by John Bossaer

ADAM VTE (apixaban for cancer-associated VTE) results have been published - let's talk about it. Also, what are the implications of long term ibrutinib on CV health? A new Blood paper offers some possible answers.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

ADAM VTE & Ibrutinib CV Toxicity

0:00 18:10

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 18 minutes long.

When was this OncoPharm episode published?

This episode was published on October 24, 2019.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.